Aspirin was found to be safe and effective in patients with a wide range of VTE risk who underwent total knee arthroplasty. Efficacy appeared to be similar among DOACs for managing cancer-related VTE, though apixaban may have more favorable safety. Patients with RA had a 57% increased risk of VTE; a 58% increased risk of DVT; and a 57% increased risk of PE. Tranexamic acid did not seem to increase risk of postoperative complications in patients undergoing total joint arthroplasty. Patients treated for isolated superficial vein thrombosis with anticoagulants still had a "substantial" risk of VTE later on. MPN-associated vascular thromboembolisms were more common in JAK2-mutated diseases and less common in CALR-mutated diseases. Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths. Take a look at these important studies relevant to anemia, venous thromboembolism, sickle cell disease, and PNH. Patients with severe LMWH are less likely to experience VTE. In the 30-day period following consultation or hospitalization for gout flares, a transient increase in the rate of ... According to authors of a recent study, venous thromboembolism (VTE) is the third most common cardiovascular disease. ... According to a study published in Lancet, the optimal dose of low-molecular-weight heparin for venous thromboembolism ... In the ORAL Surveillance study, researchers found tofacitinib showed a higher incidence of pulmonary embolism compared ... In a study, published in the European Journal of Clinical Pharmacology, researchers investigated whether Janus kinase ... Researchers conducted a study to discern clinical predictors for the development of venous thromboembolism (VTE) in ... Researchers, led by Lisa Jakobsen, evaluated the relation between different prothrombotic genotypes and a high mean ... In a recent study, Paige Weaver, from the Department of Pharmacy at the Ascension Genesys Hospital in Grand Blanc, ... Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ... Qiongjie Zhou, MD, PhD, and colleagues from the Department of Obstetrics of the Obstetrics and Gynecology Hospital of ... Researchers from the Department of Medicine and the Ottawa Hospital Research Institute at the University of Ottawa in ...